Leidos Stock Forecast, Price & News

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Leidos in the last twelve months. There are currently 1 hold rating, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Leidos stock.
View analyst ratings for Leidos or view top-rated stocks.

Wall Street analysts have given Leidos a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Leidos wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Leidos saw a drop in short interest during the month of June. As of June 15th, there was short interest totaling 1,350,000 shares, a drop of 17.7% from the May 31st total of 1,640,000 shares. Based on an average daily volume of 719,900 shares, the short-interest ratio is presently 1.9 days. Currently, 1.0% of the company's shares are short sold.
View Leidos' Short Interest.

Leidos is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021.
View our earnings forecast for Leidos.

Leidos Holdings, Inc. (NYSE:LDOS) announced its quarterly earnings results on Tuesday, August, 3rd. The aerospace company reported $1.52 EPS for the quarter, missing the Zacks' consensus estimate of $1.58 by $0.06. The aerospace company had revenue of $3.45 billion for the quarter, compared to analyst estimates of $3.38 billion. Leidos had a net margin of 5.64% and a trailing twelve-month return on equity of 24.30%. Leidos's revenue for the quarter was up 18.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.55 earnings per share.
View Leidos' earnings history.

Leidos' stock was trading at $97.97 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, LDOS stock has decreased by 2.6% and is now trading at $95.39.
View which stocks have been most impacted by COVID-19.

Leidos declared a quarterly dividend on Friday, July 30th. Investors of record on Wednesday, September 15th will be given a dividend of $0.36 per share on Thursday, September 30th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.51%. The ex-dividend date of this dividend is Tuesday, September 14th. This is a boost from Leidos's previous quarterly dividend of $0.34.
View Leidos' dividend history.

Leidos pays an annual dividend of $1.36 per share and currently has a dividend yield of 1.28%. Leidos does not yet have a strong track record of dividend growth. The dividend payout ratio of Leidos is 23.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Leidos will have a dividend payout ratio of 18.81% next year. This indicates that Leidos will be able to sustain or increase its dividend.
View Leidos' dividend history.

Leidos issued an update on its FY21 earnings guidance on Tuesday, August, 3rd. The company provided EPS guidance of $6.35-$6.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.61. The company issued revenue guidance of $13.7-$14.1 billion, compared to the consensus revenue estimate of $13.95 billion.

10 brokerages have issued 1-year target prices for Leidos' stock. Their forecasts range from $109.00 to $125.00. On average, they anticipate Leidos' share price to reach $116.38 in the next year. This suggests a possible upside of 22.0% from the stock's current price.
View analysts' price targets for Leidos or view top-rated stocks among Wall Street analysts.

636 employees have rated Leidos CEO Roger A. Krone on Glassdoor.com. Roger A. Krone has an approval rating of 85% among Leidos' employees.

Some companies that are related to Leidos include Accenture (ACN), International Business Machines (IBM), Cognizant Technology Solutions (CTSH), EPAM Systems (EPAM), Gartner (IT), Booz Allen Hamilton (BAH), Amdocs (DOX), CACI International (CACI), Teradata (TDC), ManTech International (MANT), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and ServiceSource International (SREV).
View all of LDOS's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Leidos investors own include NVIDIA (NVDA), Lockheed Martin (LMT), The Boeing (BA), AbbVie (ABBV), Johnson & Johnson (JNJ), The Walt Disney (DIS), AT&T (T), Alibaba Group (BABA), CVS Health (CVS) and Intel (INTC).

Leidos trades on the New York Stock Exchange (NYSE) under the ticker symbol "LDOS."

Leidos' stock is owned by many different retail and institutional investors. Top institutional shareholders include Victory Capital Management Inc. (2.01%), Alliancebernstein L.P. (0.82%), Sumitomo Mitsui Trust Holdings Inc. (0.47%), RE Advisers Corp (0.45%), State of Michigan Retirement System (0.28%) and New York State Common Retirement Fund (0.17%). Company insiders that own Leidos stock include David G Fubini, Gary Stephen May, Jonathan W Scholl, Miriam E John and Roy E Stevens.
View institutional ownership trends for Leidos.

LDOS stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Alliancebernstein L.P., New York State Common Retirement Fund, State of Alaska Department of Revenue, Baldwin Brothers Inc. MA, RE Advisers Corp, Asset Management One Co. Ltd., and Alpha Cubed Investments LLC. Company insiders that have sold Leidos company stock in the last year include David G Fubini, Gary Stephen May, and Miriam E John.
View insider buying and selling activity for Leidos or view top insider-selling stocks.

LDOS stock was acquired by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Kempner Capital Management Inc., Hohimer Wealth Management LLC, Zurcher Kantonalbank Zurich Cantonalbank , Tuttle Tactical Management, Cambiar Investors LLC, Gibraltar Capital Management Inc., and Oregon Public Employees Retirement Fund.
View insider buying and selling activity for Leidos or or view top insider-buying stocks.

Shares of LDOS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LDOS stock can currently be purchased for approximately $95.39.

Leidos has a market capitalization of $13.49 billion and generates $12.30 billion in revenue each year. The aerospace company earns $628 million in net income (profit) each year or $5.83 on an earnings per share basis.

Leidos employs 39,000 workers across the globe.

The following companies are subsidiares of Leidos: BECHTEL SAIC COMPANY LLC, Benham Military Communities LLC, Benham/Ellerbe Becket LLC, Dynetics, IMX Medical Management Services Inc, Leidos Arabia Company Limited, Leidos Biomedical Research Inc., Leidos CDM Solutions LLC, Leidos Consulting Engineers Inc., Leidos Cyber Inc., Leidos Engineering LLC, Leidos Europe Limited, Leidos Federal Healthcare Inc., Leidos Global Technology Corporation, Leidos Government Services Inc., Leidos Health Holdings LLC, Leidos Health LLC, Leidos Inc., Leidos Innovations Australia Pty Ltd., Leidos Innovations Corporation, Leidos Innovations Global Inc., Leidos Integrated Technology LLC, Leidos Intermediate Holdings Inc., Leidos Management Systems Designers Inc., Leidos Services Inc., Leidos Supply Limited, Mission Support Alliance LLC, QTC Holdings Inc., QTC Management Inc., QTC Medical Services Inc., Reveal Imaging Technologies Inc., Systems Made Simple Inc., Sytex Inc., The Sytex Group Inc., Varec Holdings Inc., and Varec Inc..

Leidos was founded in 1969.

The official website for Leidos is www.leidos.com.

Leidos is headquartered at 1750 PRESIDENTS STREET, RESTON VA, 20190.

Leidos' mailing address is 1750 PRESIDENTS STREET, RESTON VA, 20190. The aerospace company can be reached via phone at 571-526-6000 or via email at [email protected]